Why is albumin (human albumin) administered after paracentesis (percutaneous abdominal paracentesis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Albumin Administration After Paracentesis: Prevention of Circulatory Dysfunction

Albumin should be administered after large-volume paracentesis (>5L) at a dose of 8g per liter of ascites removed to prevent paracentesis-induced circulatory dysfunction (PICD), which can lead to increased morbidity and mortality. 1

Rationale for Albumin Administration

Albumin infusion after paracentesis serves several critical purposes:

  1. Prevention of PICD: Large-volume paracentesis can cause significant hemodynamic changes that lead to PICD in up to 70% of untreated patients 1

  2. Reduced Complications: Albumin administration significantly reduces:

    • Hyponatremia (42% reduction)
    • Renal impairment
    • Mortality (36% reduction) 1, 2
  3. Superior to Alternatives: Albumin has been proven more effective than other volume expanders (dextran, gelatin, hydroxyethyl starch, hypertonic saline) in preventing PICD 2, 3

Dosing Recommendations

For Large-Volume Paracentesis (>5L):

  • Standard dose: 8g albumin per liter of ascites removed 1
  • Administer immediately after paracentesis completion 4

For Smaller-Volume Paracentesis (<5L):

  • Risk of PICD is lower, but albumin is still recommended at the same dose (8g/L) for patients with:
    • Advanced cirrhosis
    • Acute-on-chronic liver failure
    • High risk of post-paracentesis acute kidney injury 1

Evidence for Reduced Dosing

Some evidence suggests that half-dose albumin (4g/L) may be effective in preventing PICD in selected patients:

  • A pilot study showed similar PICD rates between standard (8g/L) and half-dose (4g/L) albumin regimens 5
  • A standardized order set using graduated dosing (25g for 5-6L, 50g for 7-10L, 75g for >10L) showed no difference in adverse outcomes compared to standard dosing 6

However, these findings should be interpreted cautiously as they come from smaller studies, and major guidelines still recommend the standard 8g/L dose.

Practical Considerations

  • Timing: Administer albumin immediately after paracentesis completion 4
  • Volume limitation: Consider limiting paracentesis to <8L per session as PICD risk increases with larger volumes 4
  • Sterile technique: Perform paracentesis under strict sterile conditions 1
  • No need for coagulation testing: Routine measurement of prothrombin time and platelet count before paracentesis is not recommended 1
  • Ultrasound guidance: Consider using ultrasound guidance when available to reduce adverse events 1

Post-Paracentesis Management

  • Restart diuretics within 1-2 days after paracentesis to prevent rapid reaccumulation of ascites 4
  • Maintain low-sodium diet (≤5g/day) 4
  • Avoid medications that can worsen ascites or renal function (NSAIDs, ACE inhibitors, angiotensin II antagonists, α1-adrenergic blockers) 1

Common Pitfalls to Avoid

  1. Omitting albumin: Failing to administer albumin after large-volume paracentesis significantly increases risk of PICD, renal dysfunction, and mortality 2

  2. Substituting with other colloids: Alternative volume expanders are less effective than albumin in preventing PICD 7, 2, 3

  3. Delaying albumin administration: Albumin should be given immediately after paracentesis completion 4

  4. Inaccurate volume measurement: Underestimating ascites volume can lead to underdosing of albumin 4

  5. Multiple small-volume paracenteses: Performing repeated small-volume paracentesis offers no benefits and increases procedure-related complications 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Fluid Resuscitation Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2011

Research

Standardizing the Use of Albumin in Large Volume Paracentesis.

Journal of pharmacy practice, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.